<< IQWiG's report on autologous stem cell transplantation for soft tissue sarcoma | TGen and Scottsdale Healthcare test PHA-848125ac drug for thymic cancer >>
Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Filipino | Русский | Svenska | Polski

ADHC to acquire stem cell patents for commercial purposes

Published on December 9, 2009 at 4:23 AM · No Comments

American Diversified Holdings Corporation (Pink Sheets: ADHC) has announced, as part of its previously disclosed strategy to concentrate in developing innovative technologies in the life sciences sector, specifically targeting the fast growing stem cell arena, that the Company is actively seeking to acquire stem cell patents for the express purpose of developing these patents for commercial purposes.

The initial thrust of the program is to solicit from the country's leading companies and research institutions in this area and seek submission from them of intellectual properties for consideration of investment by ADHC.

SOURCE American Diversified Holdings Corporation

Posted in: Medical Patent News

Tags: , ,

Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading